Pursuant to its research strategy, the DZHK focuses on selected areas of translation in its clinical studies.
Early Clinical Studies
This area encompasses first-in-patient studies - early clinical trials in which, for example, pharmacogenetics and biomarkers are studied - as well as imaging studies.
Guideline Relevant Studies
These are studies that lead to a change of practical treatment recommendations. Examples are the comparison of existing therapeutic procedures and the testing of known drugs for new indications (repurposing studies), and the comparison of pacemaker and cardiac support systems and other new treatment methods.